ETFs Waters Corporation

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 15/07/2026 am IST			5-day change	1st Jan Change
376.39 ^USD	+0.85%		+0.39%	-0.91%

14/07	Goldman Sachs Adjusts Price Target on Waters to $425 From $380, Maintains Buy Rating	MT
13/07	Baird Adjusts Price Target on Waters to $418 From $387, Maintains Outperform Rating	MT

ETFs positioned on Waters Corporation

Name	YTD change	Weight	AuM
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+8.01%	0.66%	27 M€
FIRST TRUST ALPHADEX U.S. INDUSTRIALS SECTOR INDEX ETF - CAD HEDGED	0.00%	0.23%	1 M€
GOLDMAN SACHS ACTIVEBETA PARIS-ALIGNED SUSTAINABLE US LARGE CAP EQUITY UCITS ETF - USD	+10.18%	0.18%	132 M€
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	-.--%	0.14%	1,006 M€

1 2 3

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (62.3%): chromatographic analysis instruments (56% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (30.6%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (13.4%); - services (37.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.1%), industrial (30.7%), academic institutions and governmental agencies (11.2%). Net sales are distributed geographically as follows: the United States (31.6%), Americas (6.2%), China (13.4%), Japan (5.3%), Asia (14%) and Europe (29.5%).

Employees

7,900

Sector

Advanced Medical Equipment & Technology

Calendar

04/08 - Earnings release - Q2 2026

More about the company